4bases SA is a Swiss company, founded in 2013 and based in Manno (Ticino), which develops, manufactures, and markets kits based on next-generation sequencing (NGS) compatible with Oxford Nanopore for precision medicine, prevention, and research — including the detection of hereditary predispositions, mutations in cancer, and other genetic alterations — as well as its own proprietary genomic data analysis software.